Back to Agenda
Pediatrics
Session Chair(s)
Diane M Turner-Bowker, PhD
Engagement Leader
Quintiles, United States
There are a number of unique challenges and considerations when using COAs with pediatric patients. While guidance documents provide a framework for pediatric COA assessment, this is a developing field of research. More information is needed to establish sound models for the development, validation, and implementation of COAs in pediatric clinical research. This session is intended to provide a forum for in-depth discussion of methodological challenges involved in the development and use of pediatric COAs, and the pursuit of solutions that are practical yet still adhere to established principles of instrument development.
“Pediatrics does not deal with miniature men and women, with reduced doses and the same class of diseases in smaller bodies, but….it has its own independent range and horizon…” Dr. Abraham Jacobi, 1889
Program Committee Representative: Jean Paty, Quintiles
Speaker(s)
8:15AM - 8:30AM - Welcome & Introduction - "Children are Not Just Miniature Adults"
Diane M Turner-Bowker, PhD
Quintiles, United States
Engagement Leader
8:30AM - 9:15AM - Concepts & Context: COA Measurement Strategies for a Pediatric Population
Elektra Papadopoulos, MD, MPH
AbbVie, United States
Director, Patient Experience Data and Strategy
9:15AM - 10:00AM - Challenges Facing Sponsors in the Development and Use of COAs in a Pediatric Population
Elizabeth Lauren Lindner
Sucampo Pharma Americas, United States
Clinical Trial Manager, II
10:00AM - 10:30AM - Networking Break
All Participants
United States
10:30AM - 11:15AM - Implementing COAs in Pediatric Clinical Trials
Gina Calarco, BSN, MPH
Covance, United States
Director of Pediatric Strategy and Planning
Panel Discussion
Panel Discussion
United States
Have an account?